Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Roxadustat (FG-4592) treatment for anemia in dialysis-dependent (DD) and not dialysis-dependent (NDD) chronic kidney disease patients: A systematic review and meta‐analysis

Published:2020-05 Issue: Volume:155 Page:104747
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Liu Junduo,Zhang Afang,Hayden John C.,Bhagavathula Akshaya Srikanth,Alshehhi Fatema,Rinaldi Giulia,Kontogiannis Vasileios,Rahmani Jamal

Publisher

Elsevier BV

Subject

Pharmacology

Reference40 articles.

1. Global prevalence of chronic kidney disease–a systematic review and meta-analysis;Hill;PLoS One,2016

2. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016;Naghavi;Lancet,2017

3. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente;Rutkowski;Am. J. Kidney Dis.,2009

4. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease;National;Am. J. Kidney Dis.,2006

5. Mechanisms of anemia in CKD;Babitt;J. Am. Soc. Nephrol.,2012

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roxadustat alleviates metabolic traits in letrozole-induced PCOS mice;Biochemical Pharmacology;2024-11

2. The clinical efficacy of combined ESA and Roxadustat treatment for renal anemia in hemodialysis patients with secondary hyperparathyroidism: A case series;Medicine;2024-08-16

3. Fabricating Multiphasic Angiogenic Scaffolds Using Amyloid/Roxadustat-Assisted High-Temperature Protein Printing;ACS Applied Materials & Interfaces;2024-07-02

4. Effect of HIF-PHI on Vascular Calcification and Apoptosis in High Phosphate-Induced VSMCs;J BIOL REG HOMEOS AG;2024

5. The clinical efficacy of combined ESA and Roxadustat treatment for renal anemia in hemodialysis patients with secondary hyperparathyroidism;2023-12-25